Literature DB >> 29658309

Individuals with HIV-1 Subtype C Infection and Cryptococcal Meningitis Exhibit Viral Genetic Intermixing of HIV-1 Between Plasma and Cerebrospinal Fluid and a High Prevalence of CXCR4-Using Variants.

Katlego Sojane1, Richard T Kangethe1, Christina C Chang2, Mahomed-Yunus S Moosa3, Sharon R Lewin2,4, Martyn A French5,6, Thumbi Ndung'u1,7,8,9.   

Abstract

The genotypic properties of human immunodeficiency virus type 1 (HIV-1) subtype C in individuals presenting with cryptococcal meningitis (CM) are not well established. Employing single-genome amplification as well as bulk PCR, cloning and sequencing strategies, we evaluated the genetic properties of HIV-1 subtype C env in 16 antiretroviral therapy-naive study participants with CM. Eleven of the 16 participants had matched blood plasma and cerebrospinal fluid (CSF) evaluated, with the rest having either a plasma or CSF sample evaluated. Before antiretroviral therapy initiation, matched plasma and CSF-derived env sequences of all 11 participants displayed genetic intermixing between the two compartments. Overall, 7 of the 16 (∼43.8%) participants harbored CXCR4-using variants in plasma and/or CSF, according to coreceptor usage prediction algorithms. This study suggests that HIV-1 subtype C genetic intermixing between peripheral blood and the central nervous system is common in individuals presenting with CM, and that CXCR4 usage is present in one or both compartments in approximately 44% of individuals.

Entities:  

Keywords:  HIV-1; cerebrospinal fluid; cryptococcal meningitis; plasma

Mesh:

Substances:

Year:  2018        PMID: 29658309      PMCID: PMC6314437          DOI: 10.1089/AID.2017.0209

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  78 in total

1.  A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.

Authors:  Stéphane Guindon; Olivier Gascuel
Journal:  Syst Biol       Date:  2003-10       Impact factor: 15.683

2.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Authors:  G Alkhatib; C Combadiere; C C Broder; Y Feng; P E Kennedy; P M Murphy; E A Berger
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

3.  Genetic attributes of cerebrospinal fluid-derived HIV-1 env.

Authors:  Satish K Pillai; Sergei L Kosakovsky Pond; Yang Liu; Benjamin M Good; Matthew C Strain; Ronald J Ellis; Scott Letendre; Davey M Smith; Huldrych F Günthard; Igor Grant; Thomas D Marcotte; J Allen McCutchan; Douglas D Richman; Joseph K Wong
Journal:  Brain       Date:  2006-05-30       Impact factor: 13.501

4.  Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Authors:  F Gao; S G Morrison; D L Robertson; C L Thornton; S Craig; G Karlsson; J Sodroski; M Morgado; B Galvao-Castro; H von Briesen; S Beddows; J Weber; P M Sharp; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.

Authors:  L Xiao; S M Owen; I Goldman; A A Lal; J J deJong; J Goudsmit; R B Lal
Journal:  Virology       Date:  1998-01-05       Impact factor: 3.616

6.  Molecular determinants of HIV-1 subtype C coreceptor transition from R5 to R5X4.

Authors:  Hong Zhang; Damien C Tully; Tiejun Zhang; Hideaki Moriyama; Jesse Thompson; Charles Wood
Journal:  Virology       Date:  2010-08-24       Impact factor: 3.616

7.  Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.

Authors:  Christina C Chang; Afton A Dorasamy; Bernadett I Gosnell; Julian H Elliott; Tim Spelman; Saleha Omarjee; Vivek Naranbhai; Yacoob Coovadia; Thumbi Ndung'u; Mohamed-Yunus S Moosa; Sharon R Lewin; Martyn A French
Journal:  AIDS       Date:  2013-08-24       Impact factor: 4.177

8.  Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences.

Authors:  B T Korber; K J Kunstman; B K Patterson; M Furtado; M M McEvilly; R Levy; S M Wolinsky
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

9.  AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations.

Authors:  B J Brew; M Rosenblum; K Cronin; R W Price
Journal:  Ann Neurol       Date:  1995-10       Impact factor: 10.422

10.  Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms.

Authors:  Kieran Cashin; Jasminka Sterjovski; Katherine L Harvey; Paul A Ramsland; Melissa J Churchill; Paul R Gorry
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

View more
  3 in total

1.  HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi.

Authors:  Olubusuyi Moses Adewumi; Elena Dukhovlinova; Nathan Y Shehu; Shuntai Zhou; Olivia D Council; Maxwell O Akanbi; Babafemi Taiwo; Adesola Ogunniyi; Kevin Robertson; Cecilia Kanyama; Mina C Hosseinipour; Ronald Swanstrom
Journal:  AIDS Res Hum Retroviruses       Date:  2020-02-17       Impact factor: 2.205

2.  HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana.

Authors:  Nametso Kelentse; Sikhulile Moyo; Mompati L Mogwele; Doreen Ditshwanelo; Baitshepi Mokaleng; Natasha O Moraka; Kwana Lechiile; Tshepo B Leeme; David S Lawrence; Rosemary Musonda; Ishmael Kasvosve; Thomas S Harrison; Joseph N Jarvis; Simani Gaseitsiwe
Journal:  Viruses       Date:  2020-12-07       Impact factor: 5.048

3.  CXCR4 is a prognostic marker that inhibits the invasion and migration of gastric cancer by regulating VEGF expression.

Authors:  Gaoyang Chen; Zhen Zhou; Jun Jin; Yan Zhou; Yanqing Liu; Weimin Wang
Journal:  Oncol Lett       Date:  2021-06-04       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.